Gold Down 1%; ISM Manufacturing PMI Tops Estimates
Portfolio Pulse from Lisa Levin
U.S. stocks traded mixed with the Nasdaq Composite gaining and the Dow and S&P 500 falling. The ISM manufacturing PMI increased to 49 in September, above market estimates. AERWINS Technologies, IceCure Medical, and Invitae Corporation saw their shares rise after positive company news. SmileDirectClub, Intelligent Bio Solutions, and Enerflex saw their shares drop due to negative company news. Gold and oil prices fell.
October 02, 2023 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Enerflex shares fell 21% as the company announced the resignation of its Senior Vice President and Chief Financial Officer.
The resignation of the company's Senior Vice President and Chief Financial Officer has led to a drop in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Intelligent Bio Solutions shares fell 56% as the company announced pricing of $4,000,000 underwritten public offering.
The company's announcement of the pricing of a $4,000,000 underwritten public offering has led to a drop in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
SmileDirectClub shares dropped 61% after the company filed for Chapter 11 bankruptcy.
The company's filing for Chapter 11 bankruptcy has led to a significant drop in its stock price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
AERWINS Technologies shares rose 173% after the company said it is considering strategic alternatives for its non-core operations.
The company's announcement of considering strategic alternatives for its non-core operations has led to a surge in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
IceCure Medical shares rose 39% after the company announced a successful independent study validating its ProSense cryoblation treatment for breast cancer.
The successful independent study validating the company's ProSense cryoblation treatment for breast cancer has boosted its stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Invitae Corporation shares rose 14% after the FDA approved the company's DNA test to assess certain cancers.
The FDA approval of the company's DNA test to assess certain cancers has led to a rise in its stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100